These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 23944372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Value of optical coherence tomography in diagnosis of age-related macular degeneration. Correlation of fluorescein angiography and OCT findings].
    Spraul CW, Lang GE, Lang GK.
    Klin Monbl Augenheilkd; 1998 Mar; 212(3):141-8. PubMed ID: 9592738
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
    Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Klein BE, Smith W, De Jong PT.
    Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
    [Abstract] [Full Text] [Related]

  • 7. Increased expression of CD200 on circulating CD11b+ monocytes in patients with neovascular age-related macular degeneration.
    Singh A, Falk MK, Hviid TV, Sørensen TL.
    Ophthalmology; 2013 May; 120(5):1029-37. PubMed ID: 23410964
    [Abstract] [Full Text] [Related]

  • 8. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
    Alexander SL, Linde-Zwirble WT, Werther W, Depperschmidt EE, Wilson LJ, Palanki R, Saroj N, Butterworth SL, Ianchulev T.
    Ophthalmology; 2007 Dec; 114(12):2174-8. PubMed ID: 18054636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An evaluation of photographic screening for neovascular age-related macular degeneration.
    Maberley DA, Isbister C, Mackenzie P, Aralar A.
    Eye (Lond); 2005 Jun; 19(6):611-6. PubMed ID: 15184945
    [Abstract] [Full Text] [Related]

  • 11. Circulating omega-3 Fatty acids and neovascular age-related macular degeneration.
    Merle BM, Benlian P, Puche N, Bassols A, Delcourt C, Souied EH, Nutritional AMD Treatment 2 Study Group.
    Invest Ophthalmol Vis Sci; 2014 Mar 28; 55(3):2010-9. PubMed ID: 24557349
    [Abstract] [Full Text] [Related]

  • 12. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL, Yu F.
    Ophthalmology; 2008 Jan 28; 115(1):18-25. PubMed ID: 17572499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Incidence of patients presenting with exudative maculopathy and neovascular retinal disease in an urban population.
    Ergun E, Abramov A, Zawinka C, Stur M.
    Wien Klin Wochenschr; 2004 Nov 30; 116(21-22):737-43. PubMed ID: 15628644
    [Abstract] [Full Text] [Related]

  • 15. Management of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM, Pruente C.
    Prog Retin Eye Res; 2007 Jul 30; 26(4):437-51. PubMed ID: 17512238
    [Abstract] [Full Text] [Related]

  • 16. Dysregulation of CXCR3 expression on peripheral blood leukocytes in patients with neovascular age-related macular degeneration.
    Falk MK, Singh A, Faber C, Nissen MH, Hviid T, Sørensen TL.
    Invest Ophthalmol Vis Sci; 2014 May 08; 55(7):4050-6. PubMed ID: 24812555
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration.
    Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF.
    Ophthalmology; 2010 Sep 08; 117(9):1775-81. PubMed ID: 20472293
    [Abstract] [Full Text] [Related]

  • 18. Is pseudophakia a risk factor for neovascular age-related macular degeneration?
    Sutter FK, Menghini M, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Bosch MM, Helbig H.
    Invest Ophthalmol Vis Sci; 2007 Apr 08; 48(4):1472-5. PubMed ID: 17389473
    [Abstract] [Full Text] [Related]

  • 19. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
    Yamazaki T, Koizumi H, Yamagishi T, Kinoshita S.
    Ophthalmology; 2012 Aug 08; 119(8):1621-7. PubMed ID: 22551738
    [Abstract] [Full Text] [Related]

  • 20. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F, Lafuma A, Berdeaux G.
    Invest Ophthalmol Vis Sci; 2007 Jan 08; 48(1):96-103. PubMed ID: 17197522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.